Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma.

Wasmuth, J-C

Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma. [electronic resource] - European journal of medical research Oct 2008 - 483-6 p. digital

Publication Type: Case Reports; Journal Article

0949-2321


Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cyclophosphamide--adverse effects
Diagnosis, Differential
Fatal Outcome
Hepatitis B, Chronic--complications
Humans
Liver--pathology
Liver Failure, Acute--etiology
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Recurrence
Rituximab
Vidarabine--adverse effects